At the recently held Ahmedabad Pharma Summit 2025, Dr HG Koshia, Commissioner, Food & Drugs Control Administration (FDCA), Gujarat, delivered an inspiring keynote address, emphasising Gujarat’s pivotal role in India’s pharma growth story.
He lauded the summit’s theme and noted its timely relevance. Dr Koshia shared that Gujarat is home to over 5,000 licensed manufacturers across pharmaceuticals, cosmetics, and medical devices, contributing significantly to India’s pharma production and to its exports.
Highlighting Gujarat’s technological leadership, he detailed how the FDCA pioneered online licensing systems and fully digitalised product databases, enhancing transparency and efficiency. Today, the state boasts more than 56,000 licensed pharmacies operating through a centralised online platform, enabling real-time verification and monitoring.
Dr Koshia also reflected on Gujarat’s strong educational foundation, citing LM College of Pharmacy’s historic role in nurturing entrepreneurs who later founded globally recognised pharma companies. Today, Gujarat hosts over 65 pharmacy institutions, further strengthening the talent pool and innovation ecosystem.
Underscoring the state’s commitment to quality, he shared that Gujarat’s FDCA runs India’s first NABL- accredited government lab, enhancing credibility in pharmaceutical testing.
Dr Koshia also narrated how Gujarat’s regulatory systems have won international acclaim. Foreign health officials visiting Gujarat’s FDA offices expressed heightened trust in medicines sourced from the state after witnessing its transparent and tech- driven operations.
Concluding, Dr Koshia emphasised that Gujarat’s blend of science, technology, regulatory excellence, and entrepreneurial spirit positions it as a true global hub for quality pharma products. He reiterated the FDCA’s commitment to ensuring patient safety, fostering innovation, and strengthening Gujarat’s contribution to global healthcare.
The session set an optimistic tone for the summit, reinforcing the message that Gujarat will continue to lead India’s pharma advancement.